Citadel Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$460M Sell
3,821,227
-3,000,104
-44% -$346M 0.07% 197
2025
Q4
$718M Buy
6,821,331
+5,853,277
+605% +$549M 0.11% 121
2025
Q3
$81.2M Buy
+968,054
New +$79.7M 0.01% 995
2025
Q2
Sell
-2,048,739
Closed -$163M 14120
2025
Q1
$184M Sell
2,048,739
-3,232,971
-61% -$302M 0.03% 398
2024
Q4
$525M Sell
5,281,710
-1,759,979
-25% -$181M 0.09% 135
2024
Q3
$800M Sell
7,041,689
-1,200,378
-15% -$143M 0.15% 74
2024
Q2
$1.02B Buy
8,242,067
+666,847
+9% +$85.9M 0.21% 59
2024
Q1
$1,000M Buy
7,575,220
+1,257,049
+20% +$155M 0.19% 61
2023
Q4
$689M Sell
6,318,171
-358,936
-5% -$37.3M 0.14% 71
2023
Q3
$687M Buy
6,677,107
+4,837,236
+263% +$521M 0.15% 66
2023
Q2
$212M Buy
1,839,871
+1,068,727
+139% +$121M 0.04% 303
2023
Q1
$82M Sell
771,144
-1,715,524
-69% -$185M 0.02% 730
2022
Q4
$276M Sell
2,486,668
-900,548
-27% -$92.1M 0.06% 226
2022
Q3
$292M Buy
3,387,216
+1,231,726
+57% +$110M 0.07% 192
2022
Q2
$197M Sell
2,155,490
-1,233,115
-36% -$109M 0.05% 285
2022
Q1
$278M Buy
3,388,605
+1,171,399
+53% +$92.4M 0.06% 232
2021
Q4
$170M Sell
2,217,206
-871,326
-28% -$69.4M 0.03% 412
2021
Q3
$232M Buy
3,088,532
+138,422
+5% +$10.5M 0.05% 296
2021
Q2
$229M Sell
2,950,110
-1,641,974
-36% -$122M 0.05% 276
2021
Q1
$338M Sell
4,592,084
-586,644
-11% -$43.3M 0.08% 152
2020
Q4
$404M Buy
5,178,728
+2,969,387
+134% +$227M 0.11% 113
2020
Q3
$175M Buy
2,209,341
+813,904
+58% +$63.8M 0.05% 238
2020
Q2
$103M Sell
1,395,437
-107,143
-7% -$8.07M 0.04% 391
2020
Q1
$110M Buy
1,502,580
+520,585
+53% +$40.9M 0.05% 305
2019
Q4
$85.2M Sell
981,995
-1,789,114
-65% -$147M 0.04% 471
2019
Q3
$223M Buy
2,771,109
+2,044,502
+281% +$164M 0.11% 131
2019
Q2
$58.1M Sell
726,607
-604,870
-45% -$46.3M 0.03% 652
2019
Q1
$106M Sell
1,331,477
-590,451
-31% -$44.2M 0.05% 344
2018
Q4
$140M Sell
1,921,928
-3,490,915
-64% -$246M 0.08% 219
2018
Q3
$366M Buy
5,412,843
+2,018,566
+59% +$129M 0.16% 70
2018
Q2
$197M Sell
3,394,277
-2,960,808
-47% -$167M 0.1% 156
2018
Q1
$330M Sell
6,355,085
-2,477,904
-28% -$134M 0.18% 60
2017
Q4
$474M Buy
8,832,989
+8,166,391
+1,225% +$453M 0.29% 36
2017
Q3
$40.7M Sell
666,598
-1,963,728
-75% -$119M 0.03% 651
2017
Q2
$161M Buy
2,630,326
+2,204,981
+518% +$134M 0.14% 114
2017
Q1
$25.8M Buy
425,345
+237,969
+127% +$14.4M 0.02% 800
2016
Q4
$10.5M Sell
187,376
-3,182,689
-94% -$186M 0.01% 1314
2016
Q3
$201M Buy
+3,370,065
New +$197M 0.2% 57
2016
Q2
Sell
-230,543
Closed -$12.3M 7181
2016
Q1
$11.6M Sell
230,543
-274,658
-54% -$13.5M 0.01% 1080
2015
Q4
$25.5M Buy
505,201
+432,545
+595% +$21.8M 0.03% 711
2015
Q3
$3.42M Sell
72,656
-1,230,033
-94% -$65.3M ﹤0.01% 2317
2015
Q2
$70.8M Buy
1,302,689
+351,561
+37% +$19.7M 0.06% 351
2015
Q1
$52.2M Sell
951,128
-209,135
-18% -$11.8M 0.05% 463
2014
Q4
$62.9M Sell
1,160,263
-1,035,414
-47% -$57.7M 0.06% 355
2014
Q3
$124M Buy
2,195,677
+1,820,768
+486% +$102M 0.13% 133
2014
Q2
$20.7M Sell
374,909
-1,562,344
-81% -$85.2M 0.02% 790
2014
Q1
$105M Buy
1,937,253
+1,845,549
+2,013% +$95.6M 0.12% 160
2013
Q4
$4.38M Sell
91,704
-2,070,529
-96% -$94.6M 0.01% 1792
2013
Q3
$98.2M Buy
2,162,233
+2,151,501
+20,048% +$98.2M 0.15% 119
2013
Q2
$476K Buy
+10,732
New +$479K ﹤0.01% 3884

Other funds holding MRK

Citadel Advisors's MRK Position: Q1 2026 in Review

Citadel Advisors reduced its Merck (MRK) stake by 44% in Q1 2026, selling an estimated $346M and leaving 3,821,227 shares worth $460M. The position accounts for 0.07% of the portfolio, ranked #197.

Citadel Advisors first reported a position in MRK in Q2 2013 and has held it in 50 quarters since. The position peaked at $1.02B in Q2 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Citadel Advisors held 3,821,227 shares of Merck worth $460M as of Q1 2026.
  • Citadel Advisors sold 3,000,104 Merck shares in Q1 2026, an estimated $346M.
  • Merck made up 0.07% of Citadel Advisors's portfolio in Q1 2026, its #197 holding.
  • Citadel Advisors first reported a position in Merck in Q2 2013 and has held it in 50 quarters since.
  • Citadel Advisors's Merck position peaked at $1.02B in Q2 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.